SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.850-2.6%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BoredMember who wrote (10932)8/22/2018 11:43:09 AM
From: HardToFind  Read Replies (1) of 12871
 
Now ask yourself this, do the shorts have any impact on the company's ability to develop and test a product?
Not directly. But indirectly the shorts have an impact on the company's ability to raise money with which to do said development and testing...then again, maybe it is simply the terms under which money could be raised and the pain associated with said money-raising.

Generally, I think NNVC management has made their own beds, and long shareholders' beds as well.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News